中大職務
- 副院長（醫療系統）
- 內科及藥物治療學系腸胃及肝臟科教授
- 消化疾病研究所教授
- 香港中西醫結合醫學研究所教授及創始主任
- 逸夫書院副院長及校董
- 大學校董會成員
專業範疇
- 腸胃學
教育及資歷
MBChB (CUHK), MRCP (UK), MD (CUHK), FHKCP, FHKAM, FRCP (Edinburgh), FRCP (London)
專注研究
- 胃食道反流症
- 功能性腸胃病
- 腸胃動力學
- 中西醫結合醫學
更多資訊
獎項及榮譽
- 香港健康產業大獎領袖人物, 2017
- 醫學院醫學教育奬, 2014
- 醫學院名師奬, 2012
- 亞太消化周年會腸胃學新晉領袖奬, 2008
- 校長模範教學奬, 2007
- 醫學院最佳教學奬. 2005-2008 & 2011
專業服務
- 香港中文大學醫健網絡主席
- 亞洲糖尿病基金會行政會議主席
- 亞洲腸胃神經及動力學會學術委員會主席
- 亞太腸胃學聯會會長
中大教學職務
- 環球醫學領袖培訓專修組別導師及創始主任
部分論文 (只有英文版本)
Researcher ID: N-6916-2015
- Pui Kuan Cheong, Alexander C Ford, Cynthia K Y Cheung, Jessica Y L Ching, Yawen Chan, Joseph J Y Sung, Francis K L Chan, Justin C Y Wu. Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterology & Hepatology 2018; 3: 837-844.
- C.K.Y. Cheung, L.L. Lan , M. Kyaw, A.D.P. Mak, A. Chan, Y. Chan, J.C.Y. Wu. Up‐regulation of transient receptor potential vanilloid (TRPV) and down‐regulation of brain‐derived neurotrophic factor (BDNF) expression in patients with functional dyspepsia (FD). Neurogastroenterology & Motility 2018; 30: e13176.
- Cheung, C.K., Lee, Y.Y., Chan, Y., Cheong, P.K., Law, W.T., Lee, S.F., Sung, J.J., Chan, F.K., & Wu, J.C.. Decreased basal and postprandial plasma serotonin levels in patients with functional dyspepsia. Clinical Gastroenterology and Hepatology 2013; 11: 1125-1129
- Wu, J.C.Y., Lai, L.H., Chow, D.K.L., Wong, G.L.H., Sung, J.J.Y., & Chan, F.K.L. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease. Neurogastroenterology & Motility, 2011; 23, 155-e31.
- Wu, J.C.Y., Mui, L.M., Cheung, C.M.Y., Chan, Y., & Sung, J.J.Y. 2007. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007; 132: 883-889.
- Wu, J.C., Cheung, C.M., Wong, V.W., & Sung, J.J.. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clinical Gastroenterology and Hepatology 2007; 5: 690-695.
- Wu, J.C.Y., Chan, F.K.L., Ching, J.Y.L., Leung, W.K., Hui, Y., Leong, R., Chung, S.C.S., & Sung, J.J.Y. 2004. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut, 53, (2) 174-179.
- Wu JCY, Chan FKL, Ching JYL, Leung WK, Lee YT, Sung JJY. Empirical treatment based on “typical” reflux symptom is inappropriate in population with high prevalence of H. pylori infection. Gastrointest Endosc 2002: 55; 461.
- Wu JCY, Chan FKL, Lai ACW, Lee YT, Wong SKH, Leung WK, Sung JJY. Effect of H. pylori eradication on esophageal acid exposure in patients with reflux esophagitis. Aliment Pharmacol Ther 2002:16; 545.
- Wu, J.C., Sung, J.J., Ng, E.K., Go, M.Y., Chan, W.B., Chan, F.K., Leung, W.K., Choi, C.L., & Chung, S.C.S. 1999. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. The American Journal of Gastroenterology, 94, (7) 1790-1794.